β¨ Food Standards Amendment
27 JUNE 2012 NEW ZEALAND GAZETTE, No. 71
Table 2 to paragraph
| Substance |
|---|
| Erythritol |
| Isomalt |
| Polydextrose |
| Sorbitol |
(4) If a food for special medical purposes contains royal jelly as an ingredient as defined in Standard 1.2.4, the following warning statement is required -
"This product contains royal jelly which has been reported to cause severe allergic reactions and in rare cases, fatalities, especially in asthma and allergy sufferers".
Editorial note:
The requirements of sub clauses 10(3) and (4) are based on relevant aspects of clauses 2, 3 and 5 of Standard 1.2.3.
(5) Despite paragraph (1)(g), the information mentioned in subparagraph (2)(b)(ii) is not required to be on the label if the information is provided in other documentation about the food for special medical purposes.
11 Mandatory declaration
(1) A declaration of the presence in a food for special medical purposes of any of the substances listed in the Table to this clause is required if the substance is present as -
(a) an ingredient; or
(b) an ingredient of a compound ingredient; or
(c) a food additive or component of a food additive; or
(d) a processing aid or component of a processing aid.
Table to subclause 11(1)
- Added Sulphites in concentrations of 10 mg/kg or more
- Cereals containing gluten and their products, namely, wheat, rye, barley, oats and spelt and their hybridised strains
- Crustacea and their products
- Egg and egg products
- Fish and fish products
- Milk and milk products
- Peanuts and peanut products
- Sesame seeds and sesame seed products
- Soybeans and soybean products
- Tree nuts and tree nut products other than coconut from the fruit of the palm Cocos nucifera
(2) If a declaration in relation to a food for special medical purposes is required under subclause (1), the declaration must be included on the label on any package of the food.
Editorial note:
The requirement of clause 11 is based on clause 4 of Standard 1.2.3.
12 Labelling of ingredients
The label on a package of food for special medical purposes must comply with one of the following -
(a) Standard 1.2.4 of this Code;
(b) Article 6, Directive 2000/13/EC of the European Parliament and of the Council of 20 March 2000 on the approximation of the laws of the Member States relating to the labelling, presentation and advertising of foodstuffs;
(c) 21 CFR Β§ 101.4.
Next Page →
β¨ LLM interpretation of page content
π₯
Amendment No. 132 to the Food Standards Code
(continued from previous page)
π₯ Health & Social Welfare22 June 2012
Food Standards Code, Amendment, Special Medical Purposes, Labelling, Ingredients
NZ Gazette 2012, No 71